Roflumilast

TargetMol
Product Code: TAR-T1024
Supplier: TargetMol
CodeSizePrice
TAR-T1024-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1024-1mL1 mL * 10 mM (in DMSO)£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1024-10mg10mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1024-25mg25mg£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1024-50mg50mg£222.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1024-100mg100mg£283.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Roflumilast is an orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3', 5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling.
CAS:
162401-32-3
Formula:
C17H14Cl2F2N2O3
Molecular Weight:
403.21
Pathway:
Microbiology/Virology; Metabolism
Purity:
0.9964
SMILES:
FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl
Target:
PDE; RSV

References

1. Hatzelmann A, et al. Pulm Pharmacol Ther, 2010, 23(4), 235-256. 2. Hatzelmann A, et al. J Pharmacol Exp Ther, 2001, 297(1), 267-279. 3. Martorana PA, et al. BMC Pulm Med, 2008, 8:17. 4. Cortijo J, et al. Br J Pharmacol, 2009, 156(3), 534-544. 6. Ding H, et al. Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast. Int Urol Nephrol. 2017 Jul 29.